StocksMediumUpdated•Originally published 6 November 2026•Updated 6 November 2026•
1 min read
Humana Raises 2026 Guidance After Q3 Revenue Grows 26.1%
Key Facts
1Humana raised its full-year 2026 adjusted earnings per share guidance following its Q3 results.
2The guidance hike is primarily driven by lower-than-anticipated medical costs.
Humana reported third-quarter revenue of $41.16 billion, representing a 26.1% increase compared to the previous year. According to the company, the adjusted loss per share stood at $0.70, a figure that was 30.3% better than analyst expectations, leading the insurer to raise its full-year 2026 adjusted earnings guidance.
Humana closed at $411.79 on November 5, 2026, having traded between a low of $405.4 and a high of $423.97 during the session. The financial performance and subsequent guidance hike were primarily driven by lower-than-anticipated medical costs, which contributed to improved profit margins for the firm.